Prefilled Syringes or Peptide Pills? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Prefilled Syringes or Peptide Pills?
The impact of new delivery technologies in designing peptide therapies.


Pharmaceutical Technology
Volume 37, Issue 5, pp. 46-49

12. A. Lalatsa et al., Mol. Pharm. 9 (6) 1764-1774 (2012).

13. A. Lalatsa et al., Mol. Pharm. 9 (6) 1665-1680 (2012).

14. J. Oberye et al., Hum. Reprod. 15 (2) 245-249 (2000).

15. L.R. Brown, Expert Opin. Drug Deliv. 2 (1) 29-42 (2005).

16. D.R. Serrano-Lopez and A. Lalatsa, Ther. Deliv. 4 (4) 479-501 (2013).

17. N. Parquet et al., Bone Marrow Transplant 25 (9) 965-968 (2000).

18. J. Shaji and V. Patole, Indian J Pharm. Sci. 70 (3) 269-277 (2008).

19. A. Keegan, Diabetes Forecast 60 (13) 19 (2007).

20. D. Jha et al., Bioconjug. Chem. 22 (3) 319-328 (2011).

21. I. Berezowska et al., J Med. Chem. 50 (6) 1414-1417 (2007).

22. Z. Yan et al., Mol. Pharm. 8 (2) 319-329 (2011).

23. A. Bernkop-Schnurch, J Control. Rel. 52 (1-2) 1-16 (1998).

24. H. Tozaki et al., J Pharm. Pharmacol. 49 (2) 164-168 (1997).

25. V. Khutoryanskiy, Macromol. Biosci. 11 (6) 748-764 (2011).

26. B.T. Griffin and C. M. O'Driscoll, Ther. Deliv. 2 (12) 1633-1653 (2011).

27. S. Schwartz et al., Diabetes 57 (S1) A124 (2008).

28. A.K. Petrus et al., Angew. Chem. Int. Ed. Engl. 48 (6) 1022-1028 (2009).

29. A.K. Petrus et al., ChemMedChem 2 (12) 1717-1721 (2007).

30. B.A. Sabel and U. Schroeder, "Drug Targeting System, Method of Its Preparation and Use," PCT/EP1997/003099 (1997).

31. NOD Pharmaceuticals website, "NOD Tech: Enable Oral Delivery of Biopharmaceuticals," http://www.nodpharm.com/nodtech.html, accessed Apr. 4 2013.

32. U. Schroeder et al., Peptides 19 (4) 777-780 (1998).

33. D. Das and S. Lin, J Pharm. Sci. 94 (6) 1343-1353 (2005).

34. Nanomerics website, "Molecular Envelope Technology," http://www.nanomerics.com/, accessed Apr. 4, 2013.

Aikaterini Lalatsa, PhD, is a lecturer in pharmaceutics and drug delivery at the School of Pharmacy, University of Hertfordshire, College Lane Campus, Hatfield, Hertfordshire, AL10 9AB, United Kingdom.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here